Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2020 08:35 ET | Source: AZTherapies, Inc.

AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021

Last Patient/Last Visit completed on November 13th enabling full clinical database lock BOSTON, Nov. 18, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical...
October 01, 2020 08:46 ET | Source: AZTherapies, Inc.

AZTherapies Announces Leadership Transition, Appointing Marc de Garidel Chief Executive Officer and Member of the Board of Directors

BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the appointment of Marc de...
September 29, 2020 08:46 ET | Source: AZTherapies, Inc.

AZTherapies Announces Closing of $33.6 Million Series C-1 Financing Building Upon Recent $37.5 Million Series C Financing

BOSTON, Sept. 29, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the closing of a $33.6...
September 09, 2020 08:34 ET | Source: AZTherapies, Inc.

AZTherapies Doses First Patient in Phase 2a Study of ALZT-OP1a in Amyotrophic Lateral Sclerosis (ALS)

BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the dosing of the first...
August 11, 2020 08:35 ET | Source: AZTherapies, Inc.

AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board

BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the expansion of its...
July 22, 2020 08:35 ET | Source: AZTherapies, Inc.

AZTherapies Strengthens Board of Directors & Business Advisory Board with New Appointments

Noah Gottdiener of Duff & Phelps and Thierry Porté of J.C. Flowers & Co. join BOD Retired Eli Lilly executive Joseph B. Kelley joins Business Advisory Board BOSTON, July 22, 2020 (GLOBE...
February 04, 2020 08:47 ET | Source: AZTherapies, Inc.

AZTherapies to Present at 22nd Annual BIO CEO & Investor Conference

BOSTON, Feb. 04, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced its participation in the 22nd Annual BIO CEO...
December 03, 2019 08:32 ET | Source: AZTherapies, Inc.

AZTherapies Announces Publication of Data Supporting the Targeting of Neuroinflammation in the Treatment of ALS in Scientific Reports

Anti-inflammatory drug cromolyn successfully delayed disease onset and was neuroprotective in a mouse model of ALS Company expects to advance its re-engineered inhaled cromolyn candidate AZT-101...
November 06, 2019 16:05 ET | Source: AZTherapies, Inc.

AZTherapies Announces Appointment of Ernest D. Penachio as Vice President of Manufacturing Operations and CMC

BOSTON, Nov. 06, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced that Ernest D. Penachio has joined the...
November 04, 2019 08:45 ET | Source: AZTherapies, Inc.

AZTherapies to Present at the 25th Annual BIO-EUROPE® International Partnering Conference

BOSTON, Nov. 04, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced that its Director of Business Development,...

Next Page keyboard_arrow_right